117 GENES FOUND

Show / hide columns »

XML | RDF | TAB | « prev | Page of 3

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Cancer

 

 

 

 

 

 

Subcellular location

x

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SERPINB2Serpin peptidase inhibitor, clade B (ovalbumin), member 2Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Golgi apparatusGroup enriched
SERPINC1Serpin peptidase inhibitor, clade C (antithrombin), member 1Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
SERPIND1Serpin peptidase inhibitor, clade D (heparin cofactor), member 1Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
VesiclesTissue enriched
SERPINE1Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
CytosolTissue enhanced
SNAP25Synaptosomal-associated protein, 25kDaDisease related genes
FDA approved drug targets
Predicted intracellular proteins
Transporters
Tissue enriched
SYT2Synaptotagmin IIDisease related genes
FDA approved drug targets
Predicted membrane proteins
VesiclesTissue enhanced
TLR2Toll-like receptor 2CD markers
FDA approved drug targets
Predicted membrane proteins
Nucleus
Mitochondria
Tissue enhanced
TNFTumor necrosis factorCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Tissue enhanced
TNFRSF8Tumor necrosis factor receptor superfamily, member 8Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
TNFSF11Tumor necrosis factor (ligand) superfamily, member 11Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
TNFSF13BTumor necrosis factor (ligand) superfamily, member 13bCancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Mixed
TSHRThyroid stimulating hormone receptorCancer-related genes
Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
VAMP1Vesicle-associated membrane protein 1 (synaptobrevin 1)FDA approved drug targets
Predicted membrane proteins
Transporters
Mixed
VAMP2Vesicle-associated membrane protein 2 (synaptobrevin 2)FDA approved drug targets
Predicted membrane proteins
Transporters
Expressed in all
VEGFAVascular endothelial growth factor ACancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
RAS pathway related proteins
Expressed in all
VEGFBVascular endothelial growth factor BCancer-related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
RAS pathway related proteins
Expressed in all
VWFVon Willebrand factorCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Mixed

« prev | Page of 3